Astellas Pharma today announced that the US Food and Drug Administration (FDA) has approved VYLOY (zolbetuximab-clzb) in ...
"Expertly Examined" author_name="Cody McGonagill, Firefighter/EMT" author_img_id="49062"]“During my 10-plus years working as a firefighter/EMT, I had the pleasure of working for both a dual-role ...
In addition, on 24 September, the NDA for vitiligo indication of ruxolitinib cream has been accepted by the National Medical Products Administration of China (NMPA). In accordance with the relevant ...